Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease

Hepatology

Volumn 40, Issue 2, 2004, Pages 475-483

  Abrams, Gary A ^a,d   Kunde, Sachin S ^b   Lazenby, Audrey J ^c   Clements, Ronald H ^b  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; GLUCOSE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; STOMACH BYPASS;

ADULT; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FATTY LIVER; FEMALE; FIBROSIS; HUMANS; HYPERGLYCEMIA; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, MORBID; PORTAL SYSTEM; PREVALENCE; RISK FACTORS;

EID: 4043132498     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20323     Document Type: Article

References (42)

1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79.
2. Strum R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 2003;163:2146-2148.
3. Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology 2001;120:669-681.
4. Gastrointestinal surgery for severe obesity. NIH consensus development conference, March 25-7,1991. Nutrition 1996;12:397-404.
5. Schauer PR, Ikramuddin S. Laparoscopic surgery for morbid obesity. Surg Clin North Am 2001;81:1145-1179.
6. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. HEPATOLOGY 2003;37:1202-1219.
7. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
8. Kleiner DE, Brunt EM, Van Natta ML, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histologic scoring system for nonalcoholic fatty liver disease (NAFLD) and nonalcholic steatohepatitis (NASH) [abstract]. HEPATOLOGY 2003;38:233A.
9. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
10. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
11. Colman P, Thomas D, Zimmet P, Welborne T, Garcia-Webb P, Moore M. New classification and criteria for diagnosis of diabetes mellitus. Med J Aust 1999;170:375-378.
12. Molleston JP, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002;97:2460-2462.
13. Schwimmer JB, Behling C, Newbery R, McGreal N, Rauch J, Deutsch R, et al. The histological features of pediatric nonalcoholic fatty liver disease (NAFLD) [Abstract]. HEPATOLOGY 2002;36:412A.
14. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990;85:1349-1355.
15. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999;84:1513-1517.
16. Luyckx FH, Desaive C, Thiry A, Dewe W, Scheen AJ, Gielen JE, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998;22:222-226.
17. Zelman S. The liver in obesity. Arch Intern Med 1952;90:141-156.
18. Kern WH, Heger AH, Payne JH, DeWind LT. Fatty metamorphosis of the liver in morbid obesity. Arch Pathol 1973;96:342-346.
19. Campbell JM, Hunt TK, Karam JH, Forsham PH. Jejunoileal bypass as a treatment of morbid obesity. Arch Intern Med 1977;137:602-610.
20. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811-816.
21. Andersen T, Gluud C. Liver morphology, in morbid obesity: a literature study. Int J Obes 1984;8:97-106.
22. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. HEPATOLOGY 1999;30:1356-1362.
23. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-1123.
24. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? HEPATOLOGY 1998;27:1463-1466.
25. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S. adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
26. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
27. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome [erratum appears in HEPATOLOGY 2003;38:536]. HEPATOLOGY 2003;37:917-923.
28. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome [erratum appears in HEPATOLOGY 2003;38:536]. HEPATOLOGY 2003;37:917-923.
29. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979;139:667-669.
30. Schlichting P, Holund B, Poulsen H. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol 1983;18:27-32.
31. Regev A, Berho M, Jeffers LJ, Molina EG, Pyrsopoulos NT, Feng Z, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618.
32. Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little ME, Civantos F, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996;43:568-571.
33. Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J, et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 1998;11:560-565.
34. Merriman RB, Ferrell LD, Patti MG, Ostroff JW, Baretelos K, Aouizerat BE, et al. Histological correlation of paired right lobe and left lobe liver biopsies in morbidly obese individuals with suspected non-alcoholic fatty liver disease [Abstract]. HEPATOLOGY 2003;38:232A.
35. Abrams GA, Jhala N, Lazenby AJ, Kunde SS, Leath T, Ragland B, et al. Comparison of paired liver biopsies in morbidly obese subjects with nonalcoholic fatty liver disease [Abstract]. Gastroenterology 2004;126:A755.
36. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705-1725.
37. Jorens P, Vermeire P, Herman A. L-arginine dependent nitric oxide synthase: a new metabolic pathway in the lung and airways. Eur Respir J 1993;6:258-266.
38. Shaw S. Lipid peroxidation, iron mobilization and radical generation induced by alcohol. Free Radic Biol Med 1989;7:541-547.
39. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349-356.
40. Alessi MC, Morange P, Juhan-Vague I. Fat cell function and fibrinolysis. Horm Metab Res 2000;32:504-508.
41. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
42. Gregoire FM. Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med 2001;226:997-1002.